Atrás
Rango del Día
$11.24
$11.71
Rango de 52 Semanas
$9.82
$20.06
Volumen
1,014,495
Promedio 50D / 200D
$12.55
/
$13.35
Cierre Anterior
$11.82
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -9.5 | 0.3 |
| P/B | 3.8 | 2.9 |
| ROE % | -38.9 | 3.7 |
| Net Margin % | -20.8 | 3.8 |
| Rev Growth 5Y % | 5.2 | 10.0 |
| D/E | 0.9 | 0.2 |
Precio Objetivo de Analistas
Hold
$33.50
+194.9%
Low: $20.00
High: $47.00
EPS Futuro
-$1.51
Ingresos Est.
690 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$4.79
$4.49 – $5.35
|
1.8 B | 1 |
| FY2029 |
$2.45
$2.30 – $2.73
|
1.5 B | 1 |
| FY2028 |
-$0.42
-$0.50 – -$0.37
|
920 M | 3 |
Puntos Clave
Revenue grew 5.20% annually over 5 years — modest growth
Negative free cash flow of -75.68M
PEG of 0.49 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.08%
Capital efficient — spends only 4.07% of revenue on capex
Crecimiento
Revenue Growth (5Y)
5.20%
Revenue (1Y)8.28%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-38.89%
ROIC-18.30%
Net Margin-20.79%
Op. Margin-23.47%
Seguridad
Debt / Equity
0.85
Current Ratio2.90
Interest Coverage0.00
Valoración
P/E Ratio
-9.49
P/B Ratio3.80
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8.28% | Revenue Growth (3Y) | 13.43% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 5.20% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 655.35M | Net Income (TTM) | -136.23M |
| ROE | -38.89% | ROA | -16.94% |
| Gross Margin | 74.54% | Operating Margin | -23.47% |
| Net Margin | -20.79% | Free Cash Flow (TTM) | -75.68M |
| ROIC | -18.30% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.85 | Current Ratio | 2.90 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -9.49 | P/B Ratio | 3.80 |
| P/S Ratio | 1.97 | PEG Ratio | 0.49 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.29B | Enterprise Value | 1.48B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 655.35M | 605.22M | 509.34M | 537.84M | 535.03M |
| Net Income | -136.23M | -168.63M | -207.04M | -92.53M | -58.35M |
| EPS (Diluted) | -1.22 | -1.56 | -1.95 | -0.88 | -0.56 |
| Gross Profit | 488.47M | 468.04M | 381.06M | 422.97M | 420.15M |
| Operating Income | -153.80M | -170.50M | -232.87M | -89.52M | -44.33M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 804.33M | 1.24B | 1.15B | 1.19B | 1.14B |
| Total Liabilities | 463.86M | 880.61M | 783.63M | 750.48M | 729.00M |
| Shareholders' Equity | 340.47M | 360.18M | 362.50M | 441.17M | 410.49M |
| Total Debt | 290.00M | 683.35M | 596.24M | 584.27M | 581.90M |
| Cash & Equivalents | 103.39M | 163.77M | 240.82M | 115.33M | 209.61M |
| Current Assets | 646.73M | 1.11B | 1.03B | 1.11B | 1.07B |
| Current Liabilities | 223.23M | 756.38M | 179.12M | 158.78M | 142.60M |